No abstract available
Keywords:
PD-1; PD-L1; adverse effect; bullous pemphigoid; checkpoint inhibitors; immunotherapy; lung cancer; pembrolizumab; vesiculobullous.
MeSH terms
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Humans
-
Nivolumab
-
Pemphigoid, Bullous* / chemically induced
Substances
-
Antibodies, Monoclonal, Humanized
-
Nivolumab
-
pembrolizumab